Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Rani Therapeutics revenue
Rani Therapeutics's revenue is $1.0 million.
What is Rani Therapeutics's revenue?
- Rani Therapeutics's revenue growth from 2020 to 2024 is 122.51%.
- Rani Therapeutics has 75 employees, and the revenue per employee ratio is $13,706.
- Rani Therapeutics's peak quarterly revenue was $2.0M in 2021(q2).
- Rani Therapeutics peak revenue was $2.7M in 2021.
- Rani Therapeutics annual revenue for 2021 was 2.7M, 488.1% growth from 2020.
- Rani Therapeutics annual revenue for 2024 was 1.0M, -62.16% growth from 2021.
On this page
Zippi applies for you, and finds you a job.
Rani Therapeutics historical revenue
Rani Therapeutics's peak revenue was $2.7M in 2021. The peak quarterly revenue was $2.0M in 2021(q2).
Rani Therapeutics's revenue increased from $462.0k in 2020 to $1.0M currently. That's a 122.51% change in annual revenue.
Rani Therapeutics annual revenue
Rani Therapeutics annual revenue over time
| Fiscal year / year | Rani Therapeutics revenue |
|---|---|
| 2020 | $462,000 |
| 2021 | $2.7M |
| 2024 | $1.0M |
Rani Therapeutics jobs nearby
Do you work at Rani Therapeutics?
Is Rani Therapeutics transparent about its revenue structure?
Rani Therapeutics financial information
| CEO | Talat Imran |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 75 |
| Date Founded | 2012 |
| Headquarters | San Jose, California |
| Number of Locations | 1 |
| Revenue | $1.0M |
| Net Income | -$30,588,000 |
| Tax Rate | -0.0% |
| Total Assets | $108,027,000 |
| Ticker | RANI |
Rani Therapeutics jobs you might like
Rani Therapeutics financing
Rani Therapeutics received early financing of $4.0M on 2012-06-13.
| Series | Round size | Date |
|---|---|---|
| Series A | $4M | 06/2012 |
| Series B | $9.4M | 07/2013 |
| Series C | $37.1M | 05/2015 |
| Series D | $39M | 09/2017 |
| Series Unknown | $53M | 02/2018 |
| Series E | $69M | 12/2020 |
Rani Therapeutics investors
| Investors | Security type |
|---|---|
| Incube Ventures | Series A |
| InCube Ventures | Series B |
| GV | Series B |
| VentureHealth | Series B |
| Novartis | Series C |
| Western Life Sciences Venture Fund | Series C |
| STEVANATO GROUP | Series C |
| Pacific Venture Opportunity Fund | Series C |
| InCube Ventures | Series C |
| Pinemount Investment | Series C |
| GV | Series C |
| VentureHealth | Series C |
| Crystal Horizon Investments | Series C |
| Novartis | Series D |
| GV | Series D |
| ASTRAZENECA PLC | Series D |
| Virtus Inspire Ventures | Series Unknown |
| Cathay Venture | Series Unknown |
| Novartis | Series Unknown |
| GeneScience Pharmaceuticals | Series Unknown |
| SHIRE PLC | Series Unknown |
| Bossa Ventures | Series Unknown |
| Ping An Ventures | Series Unknown |
| GV | Series Unknown |
| ASTRAZENECA PLC | Series Unknown |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Rani Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Rani Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Rani Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Rani Therapeutics. The data presented on this page does not represent the view of Rani Therapeutics and its employees or that of Zippia.
Rani Therapeutics may also be known as or be related to Rani Therapeutics, Rani Therapeutics LLC and Rani Therapeutics, LLC.